The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
Open accessAbstract
The unique clinicopathologic features of Hodgkin lymphoma (HL) are due to the multiple cytokines produced by its neoplastic cells, the Hodgkin and Reed-Sternberg (HRS) cells. Cytokine signaling is mediated through the signal transducer and activator of transcription (STAT) family of transcription factors. Immunoblotting and immunohistochemistry were used to examine cell lines and tissue sections derived from patients with HL and non-Hodgkin lymphoma (NHL) for expression of activated STAT proteins. Constitutive phosphorylation of STAT6 and STAT3 was common in HL. STAT6 was constitutively phosphorylated in 5 of 5 HL cell lines and in HRS cells from 25 of 32 (78%) classical HL cases. STAT3 was constitutively phosphorylated in 4 of 5 HL cell lines and in HRS cells from 27 of 31 (87%) classical HL cases. Only 4 of 24 NHL cases demonstrated constitutive STAT6 activation, whereas STAT3 activation was observed in 6 of 13 (46%) cases of B-cell NHL and 8 of 11 (73%) cases of T-cell NHL. Constitutive STAT5 phosphorylation was not a common feature of HL or NHL. STAT6 mediates signaling by interleukin 13 (IL-13), a cytokine frequently expressed by HRS cells. Antibody-mediated neutralization of IL-13 resulted in significant decreases in both cellular proliferation and levels of phosphorylated STAT6 of HL cell lines. In conclusion, constitutive STAT6 phosphorylation is a common and distinctive feature of HRS cells in classical HL, whereas STAT3 activation was regularly present in both HL and NHL. These results suggest that IL-13 signaling is largely responsible for the constitutive STAT6 activation observed in HRS cells and further implicate IL-13 as an important growth factor in classical HL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Self-citationThe role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
Zurawski, G., & de Vries, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90021-3 · Cited by 872
Huerta, G. T., & Villasana, J. E. M. (1988) · PubMed · Cited by 804
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07100.x · Cited by 493
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
Lin, J.-X., & Leonard, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203523 · Cited by 368
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
Gires, O. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3064 · Cited by 350
The biology of Stat4 and Stat6
Wurster, A. L., Tanaka, T., & Grusby, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203485 · Cited by 309
Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells
Kapp, U., Yeh, W.-C., Patterson, B., Elia, A. J., Kägi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A., Mirtsos, C., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1939 · Cited by 276
Self-citationNieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., & Skorski, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1229 · Cited by 271
Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T.-S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13897 · Cited by 270
Andrew, D. P., Chang, M.-S., McNinch, J., Wathen, S. T., Rihanek, M., Tseng, J., Spellberg, J. P., & Elias, C. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.5027 · Cited by 266
Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice
Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T., & Akira, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3220 · Cited by 238
Skinnider, B. F. (2001) · Blood · doi:10.1182/blood.v97.1.250 · Cited by 197
Self-citationSTAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J.-W. J., Jove, R., & Koenderman, L. (1999) · Blood · doi:10.1182/blood.v94.3.1108.415k07_1108_1112 · Cited by 187
Herbst, H., Foss, H., Samol, J., Araujo, I., Klotzbach, H., Krause, H., Agathanggelou, A., Niedobitek, G., & Stein, H. (1996) · Blood · doi:10.1182/blood.v87.7.2918.bloodjournal8772918 · Cited by 187
Merz, H., Houssiau, F., Orscheschek, K., Renauld, J., Fliedner, A., Herin, M., Noel, H., Kadin, M., Mueller-Hermelink, H., & Van Snick, J. (1991) · Blood · doi:10.1182/blood.v78.5.1311.1311 · Cited by 171
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
Jücker, M., Abts, H. F., Li, W., Schindler, R., Merz, H., Günther, A., Kalle, C. V., Schaadt, M., Diamantstein, T., & Feller, A. C. (1991) · Blood · doi:10.1182/blood.v77.11.2413.2413 · Cited by 149
Teruya‐Feldstein, J., Jaffe, E. S., Burd, P. R., Kingma, D. W., Setsuda, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.8.2463.408k02_2463_2470 · Cited by 147
Izuhara, K., Heike, T., Otsuka, T., Yamaoka, K., Mayumi, M., Imamura, T., Niho, Y., & Harada, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.619 · Cited by 97
Zhang, S., Lukacs, N. W., Lawless, V. A., Kunkel, S. L., & Kaplan, M. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.10 · Cited by 85
Wang, L. H., Yang, X. Y., Kirken, R. A., Resau, J. H., & Farrar, W. L. (2000) · Blood · doi:10.1182/blood.v95.4.1249.004k39_1249_1257 · Cited by 75
Cytokine-Stimulated T Lymphocyte Proliferation Is Regulated by p27Kip1 1
Zhang, S., Lawless, V. A., & Kaplan, M. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6270 · Cited by 64
Macon, W. R., Cousar, J. B., Waldron, J. A., & Hsu, S. M. (1992) · PubMed Central · Cited by 47
Hilbert, D. M., Migone, T.-S., Kopf, M., Leonard, W. J., & Rudikoff, S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80312-x · Cited by 40
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Wynn, T. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141142 · Cited by 958
The biology of Hodgkin's lymphoma
Küppers, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2542 · Cited by 688
The role of cytokines in classical Hodgkin lymphoma
Skinnider, B. F., & Mak, T. W. (2002) · Blood · doi:10.1182/blood-2002-01-0099 · Cited by 505
Self-citationSteidl, C., Connors, J. M., & Gascoyne, R. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8401 · Cited by 374
Self-citation
Metadata
- Authors
- Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Patterson, B., Trumper, L., Kapp, U., & Mak, T. W.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-01-15
- Volume
- 99
- Issue
- 2
- Pages
- 618-626
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2004805882
- Cited by
- 288
- References
- 36
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.